Veterinary Vaccines Market
Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026
- 2017-03-02
- REP-MA-3086
- 176 pages
-
An Incisive, In-depth Analysis on the Middle East Veterinary Vaccines Market
This study offers a comprehensive, 360 degree analysis on the Middle East Veterinary Vaccines market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Middle East Veterinary Vaccines market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactAttenuated live vaccines are expected to emerge as the dominant vaccine type segment over the forecast period
Attenuated live vaccines segment is the largest segment among the vaccine type segments, which was estimated to create close to US$ 90 Mn, or more than 30% share of the total market in 2016. By the end of 2026, attenuated live vaccines segment is projected to reach more than US$ 150 Mn, expanding at a CAGR of 5.8% over the forecast period. Greater adoption of live attenuated vaccines is expected to contribute to the attractive absolute $ opportunity of the segment. Attenuated live vaccines segment is expected to be the most lucrative in the MEA veterinary vaccines market with a market attractiveness index of 2.0.
Rising incidence of food borne and zoonotic diseases in MEA countries likely to fuel the demand for attenuated live vaccines
Rising incidence of food borne and zoonotic diseases in MEA countries is fuelling the demand in the attenuated live vaccines segment in the region. As the pattern of veterinary treatment is shifting from curative/reactive to preventive, the cost of a preventive treatment is much smaller and has far less side effects than reactive treatments that often lead to mass slaughter. This is the precise reason behind driving the growth of the attenuated live vaccines segment in the MEA region. Rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This demands effective vaccination of livestock, especially in major animal farming and meat producing nations with a diversified herd in the region such as Sudan, Turkey, Egypt and KSA. Rising per capita disposable income levels are largely contributing to the rise in demand for processed food items. This is expected to drive the growth in demand for attenuated live vaccines in the poultry and livestock segments.
There are international guidelines on the usage of livestock identification and traceability systems (LITS) for better herd management, identifying zoonosis and managing animal health and incorporating food safety. However, most countries in the MEA region fail to implement proper LITS thereby affecting effective animal disease management. This is expected to fuel the demand for protective maintenance of animal health through early attenuated live vaccinations in order to avoid the spread of infectious diseases. The countries within the MEA region and Central Europe are increasingly dependent on live stock trading as a means of survival. Furthermore, in order to address chronic food insecurity in rural areas, animals are transferred from one place to another. This is fuelling demand for adequate vaccinations as an infection affecting one of the herds could easily spread to another and lead to mass losses. This factor is creating a positive impact on attenuated live vaccinations in the region.
Attenuated live vaccines are expected to witness increased demand throughout the forecast period in Jordan
The attenuated live vaccines segment is expected to witness a significant CAGR given greater adoption in commercial farms in the UAE veterinary vaccines market. Lower dosages and repetition are factors that are expected to contribute towards greater demand for attenuated live vaccines among all animal segments in Turkey. In Jordan, attenuated live vaccines are expected to witness increased demand throughout the forecast period. Lack of organised animal rearing and tracking practices hinder estimation of demand for attenuated live vaccines in Sudan.
Scenario of Local Manufacturing and Veterinary Vaccine Registration
“The MEA region accounts for a vast livestock population; however, it is largely dependent on imports for the supply of adequate veterinary vaccines. Only six countries have the facility to produce vaccines locally. These include Egypt, Jordan, Saudi Arabia, Sudan, Syria and Turkey. Local produce acceptance is higher as regulatory authorities have relatively fewer requirements for local vaccines than imported ones. The time duration for imported vaccines to obtain the required registration is also longer. Only four countries follow the international norms of OIE although the OIE has not yet established official international standards in this respect.”
--- Analyst – Healthcare, Pharmaceuticals and Medical Devices, Future Market Insights
Our expert team of analysts provide in-depth information about the various strategies adopted by the key players in the Middle East veterinary vaccines market in a new report published by Future Market Insights titled “Veterinary Vaccines Market: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026.” According to the analysts, a market player can clearly gain an advantage in terms of correct demand estimation, if it has the local presence in terms of an office set up and resources, especially to tap sudden outbreaks such as Avian Influenza. After studying the market in detail, we found that the bigger the product portfolio, the greater the ability to operate at an intra-regional level and maintaining a healthy distributor portfolio is the key to garner higher margins, product visibility and sales. We have analysed that intense competition among existing players leads comparable players to increase their available product portfolio. We have also considered the overall market approach and have come to a conclusion that veterinarians and private veterinary pharmacies are key stakeholders in the sales and distribution of essential veterinary vaccines.
We have done a comprehensive analysis of target geographies which provides a 360o forecast of various countries in the Middle East. According to our team of experts, Turkey, Egypt, UAE, and Jordan are the key markets in the MEA region. Apart from this, our extensive research focusses on distributors, who play the most important role in the route-to-market chain as the markets are largely dependent on imported vaccines. Players in the market are also concentrating on the formation of formal vaccination schedules and harmonisation of registration guidelines. A consistent marketing approach on bovine and poultry vaccines is expected which are generally administered annually or biannually.
Value chain analysis with insights on essential vaccines is the uniqueness of this report
Our exclusive report on the Middle East veterinary vaccines market starts with an overview of the parent market of veterinary vaccines. The presence of a large number of livestock animals, communal herding practices, and lack of domestic testing and vaccine manufacturing facilities are factors garnering interest in the Middle East veterinary vaccines market from industry heavyweights. We have covered the Middle East veterinary vaccines market performance in terms of revenue, followed by drivers and restraints from the supply and demand perspectives. This is followed by trends and opportunities in the Middle East veterinary vaccines market. While examining the value chain of the Middle East veterinary vaccines market, we have offered pertinent insights on the following key points:
-
Animal product supply chains are complex in nature in most Middle Eastern markets
-
Supply chains are directly dependent on product registration and authorisation norms of individual countries
-
Exceptional stakeholders such as pet shops and pet shelters could be present in case of distribution of animal vaccines
-
For fisheries, the aquaculture association of individual countries could play a pivotal role
The competitive landscape has been included in this report to provide a dashboard view of key companies operating in the Middle East veterinary vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the Middle East veterinary vaccines market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the Middle East veterinary vaccines market. Detailed profiles of veterinary vaccines manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies.
Middle East Veterinary Vaccines Market: Segmentation
|
By Country |
By Vaccine Type |
By Disease Indication |
By Animal Type |
By Distribution Channel |
|---|---|---|---|---|
|
|
|
|
|
Extensive primary and secondary research to quantify market numbers
The forecast presented for the Middle East veterinary vaccines market assesses the total revenue generated in the Middle East veterinary vaccines market. While developing the forecast, the starting point involves sizing the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome based on an analysis of supply side and demand side factors. For quantifying the market numbers, we have conducted extensive interviews with subject matter experts in the Middle East veterinary vaccines market. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the Middle East veterinary vaccines market.
As previously mentioned, the MEA veterinary vaccines market is split into various segments and all these segments have been analysed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the Middle East veterinary vaccines market.
Another key feature of this report is the analysis of the Middle East veterinary vaccines market by vaccine type, animal type, end user, disease indication and country; and the corresponding market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity analysis is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the Middle East veterinary vaccines market.
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.